Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017535 · ClinicalTrials.gov registry record · Phase 1
An Adaptive Treatment Strategy for Adolescent Depression-Continuation
A Phase 1 study of Adolescent Depression, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02017535 is a Phase 1 study of Adolescent Depression that has completed, run by University of Minnesota. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02017535, a Phase 1 study of Adolescent Depression, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy. Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment. Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personalized continuation treatment strategy to be tested in a subsequent R01 proposal.
Conditions Studied
Interventions
- BEHAVIORAL Interpersonal Psychotherapy
- DRUG Fluoxetine
Study Locations (1)
Minnesota
- University of Minnesota, Department of Psychiatry - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02017535
The ClinicalTrials.gov registry entry for NCT02017535 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adolescent Depression appearing as the primary indexed condition, and to 2 interventions - of which Interpersonal Psychotherapy is the first listed.
NCT02017535 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02017535 about?
NCT02017535 is a clinical study titled "An Adaptive Treatment Strategy for Adolescent Depression-Continuation". Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy. Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment. Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personali...
What is the current status of trial NCT02017535?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-06. Estimated completion is 2018-10-01.
What conditions does trial NCT02017535 study?
This clinical trial studies the following conditions: Adolescent Depression.
What interventions are being tested in trial NCT02017535?
The interventions under investigation include: Interpersonal Psychotherapy (BEHAVIORAL), Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT02017535?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02017535 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adolescent Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.